AGENUS INC — Director's Dealing 2015

Dec 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2015-12-28

Reporting Person: ARMEN GARO H (Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-28	Common Stock	S	44435	$4.6165	Disposed	1388369	Direct
2015-12-28	Common Stock	S	89917	$4.5947	Disposed	1298452	Direct
2015-12-29	Common Stock	S	85224	$4.5715	Disposed	1213228	Direct
2015-12-30	Common Stock	J	162000	$4.63	Disposed	1051228	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	220349	Indirect

Footnotes

F1: Dr. Armen executed the sale for tax planning purposes. Dr. Armen intends to use the net proceeds of the sale to purchase Agenus stock during an open window in 2016.

F2: Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 216,303 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.

F3: Represents shares donated to a charitable organization.